Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Nabi (NABI) -- Ignore unavailable to you. Want to Upgrade?

To: Extra Pale who wrote (287)	9/23/2000 2:59:47 PM
From: Torben Noerup Nielsen	Respond to of 354

And then there are the cows..... If a 57% reduction in the indidence of S. aureus induced bovine mastitis could be achieved using a simple vaccine, it's almost certainly a win. Thanks, Torben

To: Extra Pale who wrote (287)	9/24/2000 1:20:30 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 354

Mike, I must say that I'm surprised that NABI held up so well on Friday. Like you, I sold my major position in the stock during the recent run-up. I think I will hold off buying back until the dust settles more. Currently I'm adding to my position in AXCA. Recent news and expected Phase III results coming within the next few weeks bodes well for this biotech...one that actually has revenue and earnings. Check it out and give me your opinion.